fbpx Skip to main content

Member's Profile

Allakos Inc

Location
975 Island Drive, Suite 201
Redwood City,   CA
94065
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2015
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Allakos Inc
Biotech Company
Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory, and proliferative diseases. The Company’s lead antibody, antolimab (AK002), targets Siglec-8, an inhibitory receptor selectively expressed on human mast cells and eosinophils. Antolimab has been shown to inhibit mast cells and deplete eosinophils. Inappropriately activated eosinophils and mast cells have been identified as key drivers in a number of severe diseases affecting the gastrointestinal tract, eyes, skin, lungs and other organs.
Related News
No related news posted by this Member